Government Accepts 44 Recommendations for Regulating AI in UK Healthcare

The UK Government has accepted all 44 recommendations made by the National Commission into the Regulation of AI in Healthcare.

The decision, announced on 6 October 2026, marks a significant step towards changing how artificial intelligence-enabled medical devices are assessed, authorised and monitored.

The recommendations focus on making regulation better suited to technologies that can change over time, while maintaining patient safety.

Why does AI need different regulation?

Traditional medical devices are generally assessed against defined requirements before being made available for clinical use.

Some artificial intelligence systems present additional challenges because their performance can be affected by updates, new data and changes in how they are deployed.

An assessment carried out before a system is introduced may not provide a complete picture of how it will perform throughout its working life.

The Commission has therefore recommended a stronger focus on monitoring technologies after they have entered clinical use.

Monitoring AI throughout its working life

The proposed approach would place greater emphasis on continuing assessment.

Regulators could use evidence gathered from real-world clinical settings to identify changes in performance and potential safety concerns.

This matters because AI systems used in healthcare may influence decisions that affect diagnosis, treatment or the management of patient information.

Appropriate oversight is especially important when mistakes could have serious consequences.

What is the AI Airlock programme?

The Medicines and Healthcare products Regulatory Agency has opened applications for the third phase of AI Airlock.

The programme enables developers, healthcare professionals and regulators to examine challenges associated with AI-enabled medical devices.

Its latest phase will focus on how technologies can be monitored after deployment.

The evidence gathered is intended to help shape future regulatory guidance and policy.

What protections will patients have?

The Government's response includes commitments to improve patient involvement, transparency and access to redress where standards of care are not met.

The proposed regulatory approach also recognises that patients should have confidence in how AI tools are used in their care.

Accepting the recommendations does not mean every proposed safeguard is already in operation.

Further regulatory development and implementation will be required.

When will changes happen?

The MHRA intends to issue draft guidance by December 2026 addressing how changes to AI medical devices should be managed.

A wider implementation roadmap is expected by spring 2027.

Further consultations and regulatory work will help determine how individual proposals are introduced.

Why this matters

Artificial intelligence could assist healthcare professionals with tasks including medical image analysis, administrative processes and clinical decision support.

However, potential benefits must be balanced against concerns over reliability, privacy, fairness and accountability.

The Government's decision sets out a direction for regulation rather than providing a guarantee that AI systems will improve NHS outcomes.

What happens next?

Regulators, NHS organisations and technology developers will now work on the proposed framework.

The key test will be whether the changes provide effective safeguards while allowing genuinely useful medical technologies to reach patients.

Keep Updated UK will continue examining how artificial intelligence is introduced into public healthcare and what protections are available to patients.